Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05197101
Other study ID # PIIM
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date January 17, 2022
Est. completion date March 17, 2023

Study information

Verified date January 2022
Source The First Affiliated Hospital with Nanjing Medical University
Contact Ziyan Jiang, doctor
Phone 13512534017
Email zyjiangchm@163.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study is a randomized, controlled, observational study. 150 nulliparous women with estimated fetal weight ≥3500g at 39-40 weeks of gestation will be enrolled as subjects in the two groups is 1:1. In the experimental group, vaginal examination will be performed at 39 to 40 weeks to assess cervical conditions. If the bishop score <6, the balloon catheter combined with oxytocin induction will be planned at 40 weeks ±3 days. In the control group, one week to 41 weeks ±3 days will be expected. Vaginal examination will be performed again to evaluate cervical conditions. If the bishop score <6 points, and balloon catheter combined with oxytocin induction will be performed. After 96h, their final delivery mode will be recorded. In the following 42 days postpartum, their complications and the neonatal outcome will be followed up.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 150
Est. completion date March 17, 2023
Est. primary completion date January 17, 2023
Accepts healthy volunteers No
Gender Female
Age group 20 Years to 40 Years
Eligibility Inclusion Criteria: singleton head position pregnancy, negative Down's screening and /or NIPT screening, no malformation was found, with slight/without pregnancy complications - Exclusion Criteria:twin or multiple pregnancy, scar uterus, with contraindications to vaginal delivery, estimated fetal weight >4500g -

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
balloon catheter combined with oxytocin induction
Balloon catheter for 12 hours and oxytocin for up to 3days.If failed , they will be treated ceacrean.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
The First Affiliated Hospital with Nanjing Medical University

Outcome

Type Measure Description Time frame Safety issue
Primary vaginal birth rate After spontaneous labor for up tp 24 hous, the mode of delivery will be konwn and recorded. 24 hours
See also
  Status Clinical Trial Phase
Active, not recruiting NCT06198881 - Association Between Labor Induction and Birth Weight in Cases of Fetal Macrosomia: The MACROMODA Cohort Study
Completed NCT03726697 - Effect of Tahneek on Hypoglycemia in Newborn Infants N/A
Not yet recruiting NCT06283277 - Fetal Clavicular Measurement to Predict Fetal Macrosomia
Completed NCT03165643 - The DNA Methylation of ARHGEF11 in Macrosomia N/A
Active, not recruiting NCT03146156 - Lifestyle Intervention in Preparation for Pregnancy (LIPP) N/A
Recruiting NCT05410080 - the Efficacy of Fetal Arterial and Venous Doppler Indices in Predicting Perinatal Outcome
Terminated NCT04838431 - A First Trimester Prediction Model for Large for Gestational Age Infants: a Preliminary Study
Withdrawn NCT03218735 - Early Term Delivery Versus Expectant Management of the Large for Gestational Age Fetus N/A
Recruiting NCT06281301 - Improving Patient Understanding of Macrosomia N/A
Recruiting NCT06048510 - New Markers of Glycation to Predict Gestational Diabetes Mellitus and Macrosomia. N/A
Completed NCT05760768 - The Effect of Individualized Exercise Guidance on Pregnancy Outcome N/A
Not yet recruiting NCT05510518 - Late Gestational Diabetes Mellitus Diagnosis in Obese Women
Withdrawn NCT02478554 - Antenatal Development Evaluated Prospectively N/A